|
Romero-Sánchez MC, Alvarez-Ríos AI, Bernal-Morell E, Genebat M, Vera F, Benhnia MR, Bravo-Urbieta J, Galera-Peñaranda C, de Pablo-Bernal RS, Abad-Carrillo MA, Leal M, Ruiz-Mateos E; VIH-GEMUVIH Región de Murcia Study Group.. Maintenance of virologic efficacy and decrease in levels of ?2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy. Antiviral Res. 2014 Nov;111:26-32. doi: 10.1016/j.antiviral.2014.08.011. PubMed PMID: 25173576.
AÑO: 2014; IF: 3.938
|
25173576
|
Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19520. doi: 10.7448/IAS.17.4.19520. PubMed PMID: 25394029; PubMed Central PMCID: PMC4224842.
AÑO: 2014; IF: 5.09
|
|
Gutiérrez F, García L, Padilla S, Alvarez D, Moreno S, Navarro G, Gómez-Sirvent J, Vidal F, Asensi V, Masiá M; CoRIS. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. HIV Med. 2014 Apr;15(4):213-23. doi: 10.1111/hiv.12104. Epub 2013 Nov 11. PubMed PMID: 24215356.
AÑO: 2014; IF: 3.257
|
|
Guzmán-Fulgencio M, Jiménez JL, Jiménez-Sousa MA, Bellón JM, García-Álvarez M, Soriano V, Gijón-Vidaurreta P, Bernal-Morell E, Viciana P, Muñoz-Fernández MÁ, Resino S. ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):27-32. doi: 10.1097/QAI.0b013e3182a990e2. PubMed PMID: 23982661.
AÑO: 2014; IF: 3.935
|
|
Portilla J, Arazo P, Crusells J, Pérez-Martínez L, Martínez-Madrid O, Boix V, Moreno J, Navarro V, Rubio T, Reus S, Galera C, Bernal E, Jover F, Amador C, Baño D, Merino E, Saiz-de-la-Hoya P. Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19803. doi: 10.7448/IAS.17.4.19803. PubMed PMID: 25397547; PubMed Central PMCID: PMC4225347.
AÑO: 2014; IF: 5.09
|